CLIC: a pogram on cultivating true leadership

12 May 2012. A Program on cultivating true leadership skills helped participants became more effective team members. Solving jigsaw puzzles using leaders’ portraits, putting leader related situations into drawings, stepping oneself into a leader’s shoe and playing games involving teamworking and leadership values were among the activities enjoyed by the participants of the CLIC program (Contemporary Leadership in Community)

Tromboseprofylaxe bij ambulante patiënten met kanker?

Outpatients with cancer have an increased risk of venous thrombosis, especially during chemotherapy. Clinical trials have shown that thromboprophylaxis with low-molecular-weight heparin reduces the incidence of symptomatic venous thrombosis in these patients. An increase in major bleeding events was suggested but not confirmed in most recent trials. However, as the incidence of venous thrombosis is relatively low in the general cancer population, thromboprophylaxis should not be recommended for all cancer outpatients. Instead, to optimize the risk/benefit ratio, targeted thromboprophylaxis for patients deemed at high risk is recommended. Risk prediction models may be used to identify these high risk patients. Until results of clinical trials based on these models are published, thromboprophylaxis can be considered in patients with advanced or metastatic high risk cancers (e.g. pancreatic and lung cancer) who are receiving chemotherapy and have no increased risk of bleeding. Because of the many uncertainties, the decision to start thromboprophylaxis should always be discussed with the patien

Prevalence of colistin resistance gene (mcr-1) containing Enterobacteriaceae in feces of patients attending a tertiary care hospital and detection of a mcr-1 containing, colistin susceptible E. coli.

The emergence of the plasmid-mediated mcr colistin resistance gene in the community poses a potential threat for treatment of patients, especially when hospitalized. The aim of this study was to determine the prevalence of all currently known mcr mediated colistin resistance gene in fecal samples of patients attending a tertiary care hospital. From November 2014 until July 2015, fecal samples of patients attending the Leiden University Medical Center were collected and screened for presence of mcr using real-time PCR. Two of 576 patients were positive for mcr-1, resulting in a prevalence of 0.35%, whereas no mcr-2 was found. One of these samples was culture negative, the second sample contained a blaCMY-2 and mcr-1 containing E.coli. This strain belonged to Sequence Type 359 and serotype O177:H21. The mcr-1 containing E.coli was phenotypically susceptible to colistin with a MIC of ≤ 0.25mg/l, due to a 1329bp transposon IS10R inserted into the mcr-1 gene as identified by WGS. This prevalence study shows that mcr-1 is present in low levels patients out of the community attending a hospital. Furthermore the study underlines the importance of phenotypical confirmation of molecular detection of a mcr-1 gene

Circular presentation of the <i>mcr-1</i> containing <i>IncX4</i> plasmid in the colistin susceptible <i>E</i>.<i>coli</i>.

<p>In green the <i>mcr-1</i> sequence. In red the IS10R insertion sequence, interrupting the <i>mcr-1</i> gene at position 572. Arrows indicate open reading frames (ORFs), dark blue ORFs with annotation, light blue ORFs without annotation (hypothetical protein). Numbers indicate nucleotide positions.</p

Antibiotic phenotype with the corresponding molecular resistance of cultured <i>mcr-1</i> containing <i>E</i>.<i>coli</i>.

<p>Antibiotic phenotype with the corresponding molecular resistance of cultured <i>mcr-1</i> containing <i>E</i>.<i>coli</i>.</p

Primers and probe used to screen for the presence of <i>mcr</i>-genes.

<p>Primers and probe used to screen for the presence of <i>mcr</i>-genes.</p

Screening for Clostridioides difficile colonization at admission to the hospital: a multi-centre study.

Objectives: To assess the value of screening for Clostridioides difficile colonization (CDC) at hospital admission in an endemic setting. Methods: A multi-centre study was conducted at four hospitals located across the Netherlands. Newly admitted patients were screened for CDC. The risk of development of Clostridioides difficile infection (CDI) during admission and 1-year follow-up was assessed in patients with and without colonization. C. difficile isolates from patients with colonization were compared with isolates from incident CDI cases using core genome multi-locus sequence typing to determine whether onwards transmission had occurred. Results: CDC was present in 108 of 2211 admissions (4.9%), whereas colonization with a toxigenic strain (toxigenic Clostridoides difficile colonization [tCDC]) was present in 68 of 2211 admissions (3.1%). Among these 108 patients with colonization, diverse PCR ribotypes were found and no ‘hypervirulent’ PCR ribotype 027 (RT027) was detected (95% CI, 0–0.028). None of the patients with colonization developed CDI during admission (0/49; 95% CI, 0–0.073) or 1-year follow-up (0/38; 95% CI, 0–0.93). Core genome multi-locus sequence typing identified six clusters with genetically related isolates from patients with tCDC and CDI; however, in these clusters, only one possible transmission event from a patient with tCDC to a patient with CDI was identified based on epidemiological data. Conclusion: In this endemic setting with a low prevalence of ‘hypervirulent’ strains, screening for CDC at admission did not detect any patients with CDC who progressed to symptomatic CDI and detected only one possible transmission event from a patient with colonization to a patient with CDI. Thus, screening for CDC at admission is not useful in this setting.</p